Sort
85,873 grants matching “alzheimers”
Clinical Decision Support System for Early Detection of Cognitive Decline Using Electronic Health Records and Deep Learning
$1,121,445Jingcheng Du · Melax Technologies, Inc. · R44 · FY2023 · AG
The chromatin-based epigenome in development and aging
$1,121,136Bruce H Howard · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD
Cell Models for AD: Lipids and Related Signaling Pathways
$1,120,946Grace Y Sun · University Of Missouri-Columbia · P01 · FY2007 · AG
Identifying the origins of resilience through human single cell molecular networks, then testing them in diverse, resilient, human IPS lines
$1,120,761Christopher A. Gaiteri · Rush University Medical Center · R01 · FY2019 · AG
HABS-HD - Core G - Development Core
$1,120,553Ozioma C Okonkwo · University Of North Texas Hlth Sci Ctr · U19 · FY2022 · AG
Cellular Mechanisms Of Xenobiotic Transport
$1,120,467David Miller · National Institute Of Environmental Health Sciences · ZIA · FY2010 · ES
Epidemiology of Brain Aging in the Very Old
$1,120,457Kuakini Medical Center · U01 · FY2001 · AG
Improving Speed and Cost of Entry for Holographic Optogenetics
$1,120,423Christopher Luk Hoy · Meadowlark Optics, Inc. · R44 · FY2025 · MH
Genetically Informed Studies of Social Connectedness and Health
$1,120,261David A Sbarra · University Of Arizona · R01 · FY2025 · AG
Harnessing Proteins as Drugs: the Protectome of Cancer- and Aging-Prevention Proteins
$1,120,000Susan M. Rosenberg · Baylor College Of Medicine · DP1 · FY2024 · AG
Augmenting Cognitive Training in Older Adults - The ACT Grant
$1,119,975Adam J. Woods · University Of Florida · R01 · FY2018 · AG
Mechanisms of Risk and Resilience to Age-Related Cognitive Decline: A 60-Year Prospective Prenatal Cohort
$1,119,959William C Heindel · Brown University · R01 · FY2021 · AG
Regional, Synpatic, Cellular Modulation of Abeta Metabolism
$1,119,939David M Holtzman · Washington University · P01 · FY2016 · NS
Optimism and Dementia-Related Health Outcomes
$1,119,766Laura D Kubzansky · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AG
The Goizueta Alzheimer's Disease Research Center
$1,119,593Allan I Levey · Emory University · P30 · FY2025 · AG
A Randomized Recruitment Intervention
$1,119,584Barbara C Tilley · University Of Texas Hlth Sci Ctr Houston · U24 · FY2012 · MD
Microparticle Therapy for Cerebral Amyloid Angiopathy
$1,119,539Wolff M. Kirsch · Karamedica, Inc. · R44 · FY2021 · AG
High-Throughput System for Protease Activity Profiling
$1,119,536Igor A. Kozlov · Prognosys Biosciences, Inc. · R44 · FY2011 · GM
Alzheimer's Disease Center Core
$1,119,364University Of Pennsylvania · P30 · FY2004 · AG
Amyloid Beta Oligomer Induction of Alzheimer Disease in Nonhuman Primates
$1,119,343Michael R Weed · Virscio, Inc. · R44 · FY2020 · AG
Genetic Studies of Dementia in the Amish
$1,119,331Jonathan L. Haines · Vanderbilt University · R01 · FY2007 · AG
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's disease
$1,119,254Jeremy H. Herskowitz · University Of Alabama At Birmingham · R01 · FY2018 · AG
Structurally Diverse GABA-A ÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂÃÂñ5 Positive Allosteric Modulators for Treatment of MCI due to AD
$1,118,843Sharon Rosenzweig-Lipson · Agenebio, Inc. · R44 · FY2019 · AG
Leveraging the Electronic Health Record and Integrating Social and Biological Data to Expand Dementia Research in Understudied Populations in Los Angeles County
$1,118,802Keith Alan Vossel · University Of California Los Angeles · UH3 · FY2025 · AG
NPTX2: Preserving memory circuits in normative aging and Alzheimer's Disease
$1,118,505Carol A. Barnes · University Of Arizona · R01 · FY2022 · AG